NYSE Arca News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 53,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "874e10e5-2429-4010-a27a-bddbd3a7434c",
"title": "Why I Made 3.4% Yielding SCHD My Largest ETF Holding (NYSEARCA:SCHD)",
"description": "SCHD has a long history of net asset value growth. Read why SCHD ETF offers a compelling value proposition for passive income investors.",
"keywords": "",
"snippet": "Torsten Asmus\n\nThe Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) continues to make a compelling value proposition for passive income investors even after the ...",
"url": "https://seekingalpha.com/article/4679023-schd-why-i-made-3-4-percent-yielding-etf-my-largest-holding",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1706231587/image_1706231587.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T02:53:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SCHD",
"name": "Schwab U.S. Dividend Equity ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 139.98123,
"sentiment_score": 0.441045,
"highlights": [
{
"highlight": "Torsten Asmus\n\nThe <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> (<em>NYSEARCA:SCHD</em>) continues to make a compelling value proposition for passive income investors even after the latest inflation update suggested that inflation may be more stubborn than anticipated.\n\nThe <em>Schwab</em> <em>U.S</em>.",
"sentiment": 0.2815,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Dividend</em> <em>Equity</em> <em>ETF</em> has a long history of providing growing stream of income to the ETF’s investors which is what ultimately backs up the value of an investment in the exchange-traded fund.\n\nThe <em>Schwab</em> <em>U.S</em>.",
"sentiment": 0.4404,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Dividend</em> <em>Equity</em> <em>ETF</em> provides stable and predictable dividend income in both low- and high-interest rate periods and has an impressive long-term net asset value growth record.\n\nThough the ETF underperformed in a shorter time frame, the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> is worthy of a portfolio overweighting, in my view.",
"sentiment": 0.9153,
"highlighted_in": "main_text"
},
{
"highlight": "My Rating History\n\nI evaluated the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> as a Buy in December 2023 because the exchange-traded fund produced 12% plus annual NAV returns in the long run and offered passive income investors a diversified portfolio that included some of the biggest U.S. corporations.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "Top 10 Holdings (<em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em>)\n\nShort-Term Underperformance\n\nIn the long-term (since 2011), the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> produced 13% annualized returns, but the ETF achieved less than half of this return in the last year which is when SCHD gained only 4.6% in value.",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "Standardized Quarterly Total Return (<em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em>)\n\nSmall Premium To NAV\n\nThe <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> is an exchange-traded fund and as such trades around net asset value. Small discounts or premiums to net asset value are therefore the norm for the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em>.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
},
{
"highlight": "Data by YCharts\n\nA Potential Short-Coming Of The Investment Thesis\n\nThe <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> has produced passive income for investors ever since its inception in 2011. With that being said, though, the exchange-traded fund is concentrated in US equities which makes the <em>Schwab</em> <em>U.S</em>.",
"sentiment": 0.2023,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Dividend</em> <em>Equity</em> <em>ETF</em> a pro-cyclical, equity-focused investment vehicle that might see substantial net asset value declines if the U.S. economy were to fall into a recession.\n\nAs such, I think the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> might not be the best choice for some safety-minded investors due to the ETF’s concentrated equity posture.",
"sentiment": 0.2412,
"highlighted_in": "main_text"
},
{
"highlight": "My Conclusion\n\nThe <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> produced solid passive income for investors and has done so for a long time, and, thus, I made SCHD my largest portfolio holding.",
"sentiment": 0.34,
"highlighted_in": "main_text"
},
{
"highlight": "As long as the U.S. economy doesn’t have to grapple with a recession, I am confident that the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> can make a positive portfolio income contribution.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "Why I Made 3.4% Yielding SCHD My Largest ETF Holding (<em>NYSEARCA:SCHD</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": [
{
"uuid": "7e426049-2059-450c-8ede-19f886c9502c",
"title": "DFJ ETF: Japan Is Different This Time, Consider Buying Small Caps On Dips (NYSEARCA:DFJ)",
"description": "The WisdomTree Japan SmallCap Dividend Fund ETF (DFJ) offers exposure to dividend-paying Japanese small cap companies with growth potential. Read more here.",
"keywords": "",
"snippet": "Eoneren\n\nDFJ overview\n\nThe WisdomTree Japan SmallCap Dividend Fund ETF (NYSEARCA:DFJ) is an efficient way for investors to get exposure to listed Japanese small...",
"url": "https://seekingalpha.com/article/4679009-dfj-japan-is-different-this-time-consider-buying-small-caps-on-dips",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1005853368/image_1005853368.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T00:32:44.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SCJ",
"name": "iShares MSCI Japan Small-Cap ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 32.84133,
"sentiment_score": 0,
"highlights": [
{
"highlight": "Let’s look at DFJ relative to the <em>iShares</em> <em>MSCI</em> <em>Japan</em> <em>Small</em>-<em>Cap</em> <em>ETF</em> (SCJ) and Japan Smaller Capitalization Fund (JOF). Note that the latter is a closed-end fund so the total returns analysis shall include some movement in the discount to NAV. For JOF over the last five years, though, the discount has widened by approximately a few percent.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "EWJ",
"name": "iShares MSCI Japan ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 27.598347,
"sentiment_score": 0,
"highlights": [
{
"highlight": "To illustrate this, below I have compared the returns of DFJ to the <em>iShares</em> <em>MSCI</em> <em>Japan</em> <em>ETF</em> (EWJ).\n\nFive year total returns DFJ v EWJ, Seeking Alpha\n\nThere are reasons however to expect this positive sentiment in the Japan stock market will spread more to small caps in the years ahead.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DFJ",
"name": "WisdomTree Japan SmallCap Dividend Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 77.836334,
"sentiment_score": 0.3062,
"highlights": [
{
"highlight": "Eoneren\n\nDFJ overview\n\nThe <em>WisdomTree</em> <em>Japan</em> <em>SmallCap</em> <em>Dividend</em> <em>Fund</em> ETF (<em>NYSEARCA:DFJ</em>) is an efficient way for investors to get exposure to listed Japanese small-cap companies that pay regular dividends. They tend to be companies more linked to local economic growth in Japan compared to some of the larger export orientated listed companies.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "DFJ ETF: Japan Is Different This Time, Consider Buying Small Caps On Dips (<em>NYSEARCA:DFJ</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "^J202.JO",
"name": "Small Cap Index",
"exchange": null,
"exchange_long": null,
"country": "za",
"type": "index",
"industry": "N/A",
"match_score": 13.444931,
"sentiment_score": 0.5859,
"highlights": [
{
"highlight": "The WisdomTree Japan SmallCap Dividends Index that this ETF tracks, has built up some significant outperformance over the MSCI Japan <em>Small</em> <em>Cap</em> <em>Index</em>.\n\nDFJ peers’ analysis\n\nAnother way to look at the benefit of using a dividend factor tilt with Japan’s small companies is to examine DFJ versus some peers.",
"sentiment": 0.5859,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "EWJ.MX",
"name": "iShares MSCI Japan ETF",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "etf",
"industry": "N/A",
"match_score": 27.5985,
"sentiment_score": 0,
"highlights": [
{
"highlight": "To illustrate this, below I have compared the returns of DFJ to the <em>iShares</em> <em>MSCI</em> <em>Japan</em> <em>ETF</em> (EWJ).\n\nFive year total returns DFJ v EWJ, Seeking Alpha\n\nThere are reasons however to expect this positive sentiment in the Japan stock market will spread more to small caps in the years ahead.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DFJ.MX",
"name": "WisdomTree Japan SmallCap Dividend Fund",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "etf",
"industry": "N/A",
"match_score": 31.685722,
"sentiment_score": 0.6124,
"highlights": [
{
"highlight": "Eoneren\n\nDFJ overview\n\nThe <em>WisdomTree</em> <em>Japan</em> <em>SmallCap</em> <em>Dividend</em> <em>Fund</em> ETF (NYSEARCA:DFJ) is an efficient way for investors to get exposure to listed Japanese small-cap companies that pay regular dividends. They tend to be companies more linked to local economic growth in Japan compared to some of the larger export orientated listed companies.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "EWJ.SN",
"name": "iShares MSCI Japan ETF",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 27.598621,
"sentiment_score": 0,
"highlights": [
{
"highlight": "To illustrate this, below I have compared the returns of DFJ to the <em>iShares</em> <em>MSCI</em> <em>Japan</em> <em>ETF</em> (EWJ).\n\nFive year total returns DFJ v EWJ, Seeking Alpha\n\nThere are reasons however to expect this positive sentiment in the Japan stock market will spread more to small caps in the years ahead.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "b4379f1c-9642-4315-ae45-9ddc69147b5a",
"title": "LQDH: A Corporate Spreads Play (NYSEARCA:LQDH)",
"description": "LQDH isolates corporate credit spreads and gains when spreads tighten, but loses value when spreads widen. Read why LQDH ETF is a Sell.",
"keywords": "",
"snippet": "Shutthiphong Chandaeng\n\nThesis\n\nThe world of exchange traded funds has become a very diversified one, with retail investors now having a plethora of options in ...",
"url": "https://seekingalpha.com/article/4679020-lqdh-etf-corporate-spreads-play-rating-downgrade",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1492180527/image_1492180527.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T02:22:29.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "LQDH",
"name": "iShares Interest Rate Hedged Corporate Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 109.12865,
"sentiment_score": 0.40515,
"highlights": [
{
"highlight": "The <em>iShares</em> <em>Interest</em> <em>Rate</em> <em>Hedged</em> <em>Corporate</em> <em>Bond</em> <em>ETF</em> (<em>NYSEARCA:LQDH</em>) is a fixed income exchange traded fund that falls in the 'hedging' ETF category. The fund is a take on the very popular iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD), which provides investors with exposure to investment grade corporate bonds.",
"sentiment": 0.4703,
"highlighted_in": "main_text"
},
{
"highlight": "LQDH: A Corporate Spreads Play (<em>NYSEARCA:LQDH</em>)",
"sentiment": 0.34,
"highlighted_in": "title"
}
]
},
{
"symbol": "LQD",
"name": "iShares iBoxx $ Investment Grade Corporate Bond ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 56.338753,
"sentiment_score": 0.2415,
"highlights": [
{
"highlight": "The fund is a take on the very popular <em>iShares</em> <em>iBoxx</em> $ <em>Investment</em> <em>Grade</em> <em>Corporate</em> <em>Bond</em> <em>ETF</em> (LQD), which provides investors with exposure to investment grade corporate bonds.\n\nWe wrote an initial coverage piece on LQDH a year ago, where we warned investors that LQDH will underperform LQD in a decreasing rates environment.",
"sentiment": 0.2415,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "209b66bb-f0f8-44b7-a6b0-5e7e265ddbfa",
"title": "ROBT ETF: Too Diversified For Reliable Alpha (NASDAQ:ROBT)",
"description": "The First Trust AI & Robotics ETF offers focused exposure to automation and AI, but has underperformed the market in recent years. Read more on ROBT ETF here.",
"keywords": "",
"snippet": "SweetBunFactory/iStock via Getty Images\n\nInvesting in AI ETFs carries specific risks that I personally do not like to take on. Primarily, these relate to specul...",
"url": "https://seekingalpha.com/article/4679016-robt-too-diversified-for-reliable-alpha",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1654943682/image_1654943682.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T01:32:19.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "ARKK",
"name": "ARK Innovation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 16.474442,
"sentiment_score": 0.8646,
"highlights": [
{
"highlight": "This can also be seen in companies like Tesla (TSLA), Zoom (ZM), and the <em>ARK</em> <em>Innovation</em> <em>ETF</em> (ARKK):\n\nAuthor, Using Seeking Alpha\n\nFrom my analysis, although the significant valuation premium continues for many of the firms listed in the ROBT ETF, investors can be more confident they are getting a good deal at present valuations than in 2021.",
"sentiment": 0.8646,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "0b0f3df1-e5cc-45f2-94fb-3899b0c49eb0",
"title": "AUSF ETF: Interesting Multi-Factor Strategy, But Hardly Compelling Returns (NYSEARCA:AUSF)",
"description": "The passively-managed AUSF ETF lacks consistent outperformance and has a tilt toward less volatile stocks. Read an investment analysis of AUSF here.",
"keywords": "",
"snippet": "bgsmith\n\nMy dear long-term readers certainly remember that I pay special attention to multi-factor equity exchange-traded funds. Today, I would like to assess y...",
"url": "https://seekingalpha.com/article/4679002-ausf-global-x-adaptive-us-etf-multi-factor-strategy-hardly-compelling-returns",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/626194278/image_626194278.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-19T00:14:32.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "DYNF",
"name": "BlackRock U.S. Equity Factor Rotation ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 33.51185,
"sentiment_score": 0.8316,
"highlights": [
{
"highlight": "AUSF is not ahead of the actively managed <em>BlackRock</em> <em>U.S</em>. <em>Equity</em> <em>Factor</em> <em>Rotation</em> <em>ETF</em> (DYNF) either, a fund I have a Hold rating on. I would like to discuss all that in greater depth below in the note.\n\nHow does AUSF manage the portfolio?\n\nAccording to the Global X website, the ETF is managed passively, with the Adaptive Wealth Strategies U.S.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IVV",
"name": "iShares Core S&P 500 ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 29.298065,
"sentiment_score": -0.2837,
"highlights": [
{
"highlight": "I believe its inability to beat the <em>iShares</em> <em>Core</em> <em>S</em>&<em>P</em> <em>500</em> <em>ETF</em> (IVV) consistently in the past was most likely the consequence of the backward-looking approach of its underlying index. It did not fully protect it from steep drawdowns amid sell-offs as well.",
"sentiment": -0.2837,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "OMFL",
"name": "Invesco Russell 1000 Dynamic Multifactor ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 41.151527,
"sentiment_score": 0.3182,
"highlights": [
{
"highlight": "My opinion is that AUSF does not have an edge over the macro-focused <em>Invesco</em> <em>Russell</em> <em>1000</em> <em>Dynamic</em> <em>Multifactor</em> <em>ETF</em> (OMFL), which I rated a Buy twice, with the most recent article presented in February. AUSF is not ahead of the actively managed BlackRock U.S. Equity Factor Rotation ETF (DYNF) either, a fund I have a Hold rating on.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 17.814991,
"sentiment_score": -0.18045,
"highlights": [
{
"highlight": "I believe its inability to beat the iShares Core <em>S</em>&<em>P</em> <em>500</em> ETF (IVV) consistently in the past was most likely the consequence of the backward-looking approach of its underlying index. It did not fully protect it from steep drawdowns amid sell-offs as well.",
"sentiment": -0.2837,
"highlighted_in": "main_text"
},
{
"highlight": "Moreover, in 2020, its worst month was March, as it underperformed the <em>S</em>&<em>P</em> <em>500</em> ETF by 10.7%, implying it was completely unprepared for the coronavirus sell-off. It showed some healthy dynamics in the months that followed, yet it still dismally trailed the bellwether ETF by 17.1% in the pandemic-torn year.",
"sentiment": -0.0772,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^RUI",
"name": "Russell 1000",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 11.994625,
"sentiment_score": 0.5994,
"highlights": [
{
"highlight": "My opinion is that AUSF does not have an edge over the macro-focused Invesco <em>Russell</em> <em>1000</em> Dynamic Multifactor ETF (OMFL), which I rated a Buy twice, with the most recent article presented in February. AUSF is not ahead of the actively managed BlackRock U.S. Equity Factor Rotation ETF (DYNF) either, a fund I have a Hold rating on.",
"sentiment": 0.5994,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "5b46b43d-c9c4-444f-a064-b54ca6c97244",
"title": "Leveraging Silver With The SILJ ETF (NYSEARCA:SILJ)",
"description": "Amplify Junior Silver Miners ETF is inexpensive, and silver is approaching an upside breakout level. Find out why I think SILJ could be a good investment choice.",
"keywords": "",
"snippet": "asbe\n\nSilver had been dead in the water in 2024, with only a $2.60 per ounce range on the continuous futures contract until last week, when the price reached a ...",
"url": "https://seekingalpha.com/article/4678941-leveraging-silver-with-the-silj-etf",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1315604894/image_1315604894.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T18:00:44.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SILJ",
"name": "ETFMG Prime Junior Silver Miners ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 99.77025,
"sentiment_score": 0.4633,
"highlights": [
{
"highlight": "In an October 24, 2023, Seeking Alpha article on the Amplify Junior Silver Miners ETF (<em>NYSEARCA:SILJ</em>), I wrote:\n\nI am bullish on silver because the price held up well during the recent correction. Geopolitical factors are trumping interest rates and currency markets.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "<em>ETFMG</em> <em>Prime</em> <em>Junior</em> <em>Silver</em> <em>Miners</em> <em>ETF</em> could be the product of choice in the current environment.\n\nOn October 24, 2023, the unleveraged SILJ product was at the $8.74 per share level. At $9.45 on March 18, SILJ was over 8% higher. I continue to favor this product as the odds favor rising silver prices after the current consolidation period ends.",
"sentiment": 0.765,
"highlighted_in": "main_text"
},
{
"highlight": "Leveraging Silver With The SILJ ETF (<em>NYSEARCA:SILJ</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
]
},
{
"uuid": "6af0fbcb-fc08-4494-8ac6-56e4b1635c0c",
"title": "IHI: Technological Advances Will Continue Carrying This High-Performing Medical ETF",
"description": "iShares U.S. Medical Devices ETF warrants a buy rating due to its top holdings' ability to capture strong returns. Read more to see my analysis on IHI.",
"keywords": "",
"snippet": "shapecharge\n\nInvestment Thesis\n\niShares U.S. Medical Devices ETF (NYSEARCA:IHI) warrants a buy rating due to multiple factors impacting the fund. While IHI has ...",
"url": "https://seekingalpha.com/article/4678930-ihi-technological-advances-will-continue-carrying-this-high-performing-medical-etf",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/592647720/image_592647720.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T17:15:32.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "^SPX",
"name": "S&P 500 INDEX",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 24.126259,
"sentiment_score": 0.71055,
"highlights": [
{
"highlight": "Of the funds compared, only IHI has outperformed the <em>S</em>&<em>P</em> <em>500</em> <em>Index</em> over the past decade.\n\n10-Year Total Price Return: IHI and Compared Health Care Funds (Seeking Alpha)\n\nAlthough IHI has demonstrated the greatest price return over the past 10 years, one downside is its fees.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the <em>S</em>&<em>P</em> <em>500</em> <em>Index</em> over the past year.\n\nOne-Year Performance: IHI and Peer Health Care & Medical Device ETFs (Seeking Alpha)\n\nOne downside for IHI is its current valuation compared to the peer funds examined.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ISRG",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.91593,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABT",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.707993,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.799889,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.BA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "ar",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.79979,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABT.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "Healthcare",
"match_score": 36.707397,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ABTCL.SN",
"name": "Abbott Laboratories",
"exchange": null,
"exchange_long": null,
"country": "cl",
"type": "equity",
"industry": "N/A",
"match_score": 36.707397,
"sentiment_score": 0.64824,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, <em>Abbott</em> <em>Laboratories</em> (ABT) and Intuitive Surgical, Inc. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "Forecast Medical Device Market Growth, 2020-2030 (www.grandviewresearch.com)\n\n<em>Abbott</em> <em>Laboratories</em>: Fulfilling Heart and Glucose Monitoring Demand\n\nIHI’s top holding, ABT, is one key company poised to take advantage of this medical device industry growth. Abbott saw a strong 2023 with 11.6% increase in sales growth.",
"sentiment": 0.9633,
"highlighted_in": "main_text"
},
{
"highlight": "Therefore, <em>Abbott</em> <em>Laboratories</em> is a fundamental holding that will drive IHI’s future price return.\n\nIntuitive Surgical: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. Intuitive Surgical is well known for its development of the da Vinci surgical robotics system.",
"sentiment": 0.3129,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including <em>Abbott</em> <em>Laboratories</em> and Intuitive Surgical that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "PSCH",
"name": "Invesco S&P SmallCap Health Care ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 35.797073,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the SPDR S&P Health Care Equipment ETF (XHE), the <em>Invesco</em> <em>S</em>&<em>P</em> <em>SmallCap</em> <em>Health</em> <em>Care</em> <em>ETF</em> (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^JI0020.JO",
"name": "Health Care Index",
"exchange": null,
"exchange_long": null,
"country": "za",
"type": "index",
"industry": "N/A",
"match_score": 14.29501,
"sentiment_score": 0.8658,
"highlights": [
{
"highlight": "PSCH seeks to capture the performance of the S&P SmallCap600 Capped <em>Health</em> <em>Care</em> <em>Index</em>. The fund therefore includes small-cap value and growth holdings. VHT tracks the MSCI U.S. Investable Market Health Care 25/50 Index. The fund is passively managed and includes small, mid, and large cap holdings within the health care market sector in general.",
"sentiment": 0.8658,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XHE",
"name": "SPDR S&P Health Care Equipment ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 32.55597,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> <em>ETF</em> (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IHI",
"name": "iShares U.S. Medical Devices ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 32.704197,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "shapecharge\n\nInvestment Thesis\n\n<em>iShares</em> <em>U.S</em>. <em>Medical</em> <em>Devices</em> <em>ETF</em> (<em>NYSEARCA:IHI</em>) warrants a buy rating due to multiple factors impacting the fund. While IHI has the highest expense ratio compared to peer medical device and healthcare funds, it also has demonstrated the greatest long-term performance.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-NV",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135712,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-EU",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-IV",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^XHE-TC",
"name": "SPDR S&P HEALTH CARE EQUIPMENT ",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 27.135658,
"sentiment_score": 0.8625,
"highlights": [
{
"highlight": "For comparison purposes, other funds examined are the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Health</em> <em>Care</em> <em>Equipment</em> ETF (XHE), the Invesco S&P SmallCap Health Care ETF (PSCH), and the Vanguard Health Care ETF (VHT). XHE tracks the S&P Health Care Equipment Select Industry Index.",
"sentiment": 0.8625,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 17.024155,
"sentiment_score": 0.71055,
"highlights": [
{
"highlight": "Of the funds compared, only IHI has outperformed the <em>S</em>&<em>P</em> <em>500</em> Index over the past decade.\n\n10-Year Total Price Return: IHI and Compared Health Care Funds (Seeking Alpha)\n\nAlthough IHI has demonstrated the greatest price return over the past 10 years, one downside is its fees.",
"sentiment": 0.7506,
"highlighted_in": "main_text"
},
{
"highlight": "Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the <em>S</em>&<em>P</em> <em>500</em> Index over the past year.\n\nOne-Year Performance: IHI and Peer Health Care & Medical Device ETFs (Seeking Alpha)\n\nOne downside for IHI is its current valuation compared to the peer funds examined.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.DE",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "de",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.799873,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "IHI.MX",
"name": "iShares U.S. Medical Devices ETF",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "etf",
"industry": "N/A",
"match_score": 25.855957,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "shapecharge\n\nInvestment Thesis\n\n<em>iShares</em> <em>U.S</em>. <em>Medical</em> <em>Devices</em> <em>ETF</em> (NYSEARCA:IHI) warrants a buy rating due to multiple factors impacting the fund. While IHI has the highest expense ratio compared to peer medical device and healthcare funds, it also has demonstrated the greatest long-term performance.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "ISRG.MX",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.917603,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LLY.MX",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "mx",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.800976,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0R29.L",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 28.916973,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "0Q1G.L",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "gb",
"type": "equity",
"industry": "N/A",
"match_score": 17.800919,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LILY34.SA",
"name": "Eli Lilly and Company",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 17.800636,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "VHT has performed well over the past year predominantly due to its top holding of <em>Eli</em> <em>Lilly</em> <em>and</em> <em>Company</em> (LLY) which has seen a 128% one-year return. Primarily due to strong returns of the “magnificent seven” big tech companies uplifting the market overall, IHI has also underperformed the S&P 500 Index over the past year.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "I1SR34.SA",
"name": "Intuitive Surgical, Inc.",
"exchange": null,
"exchange_long": null,
"country": "br",
"type": "equity",
"industry": "Healthcare",
"match_score": 28.916515,
"sentiment_score": 0.625217,
"highlights": [
{
"highlight": "Additionally, although IHI has multiple valuation metrics higher than competitor funds, the iShares ETF has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that are already taking advantage of several medical technology breakthroughs.",
"sentiment": 0.25,
"highlighted_in": "main_text"
},
{
"highlight": "Additionally, IHI’s top two holdings, Abbott Laboratories (ABT) and <em>Intuitive</em> <em>Surgical</em>, <em>Inc</em>. (ISRG), are both uniquely postured to take advantage of strong sales growth in their respective business segments. ABT and ISRG together make up almost 30% of IHI’s holdings weight. These unique advantages for IHI are discussed in further detail below.",
"sentiment": 0.9186,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Intuitive</em> <em>Surgical</em>: Leading the Way in Surgical Robotics Despite Lawsuits\n\nThe second key holding for IHI driving future returns is ISRG. <em>Intuitive</em> <em>Surgical</em> is well known for its development of the da Vinci surgical robotics system. Importantly for ISRG, the company received FDA approval for the da Vinci 5 just this past week.",
"sentiment": 0.7701,
"highlighted_in": "main_text"
},
{
"highlight": "In 2018, a class action lawsuit was settled by <em>Intuitive</em> <em>Surgical</em> for $42.5M. However, the company has continued to make updates, improvements, and released newer models. ISRG has seen a 69% price return over the past year and demonstrates strong fundamentals including a 14.5% YoY revenue growth and 25.4% net income margin.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "In addition to numerous advances in the medical device industry, IHI has several key holdings including Abbott Laboratories and <em>Intuitive</em> <em>Surgical</em> that have made key advances in their respective business segments. IHI is therefore poised to continue seeing strong returns consistent with its performance history.",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "However, risks exist for the fund including lawsuits for medical devices and competition that will encroach on the successful products of Abbott and <em>Intuitive</em> <em>Surgical</em>. Finally, despite IHI’s track record for performance, it currently has a relatively high expense ratio and P/E ratio compared to peer funds.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "c36f8dad-5bca-49a7-9a84-74df3a069ba5",
"title": "Conservative investment fund divests from Tyson Foods over migrant hiring",
"description": "A conservative oriented ETF is divesting its stake in Tyson Foods over the company's plans to hire migrants and refugees amid the ongoing crisis at the southern border.",
"keywords": "",
"snippet": "A conservative-oriented investment fund is divesting from Tyson Foods over the company's plans to hire migrants and refugees that the fund believes will alienat...",
"url": "https://www.foxbusiness.com/politics/conservative-investment-fund-divests-from-tyson-foods-over-migrant-hiring",
"image_url": "https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2024/03/0/0/Tyson-Foods-Stock-Ticker.jpg?ve=1&tl=1",
"language": "en",
"published_at": "2024-03-18T23:57:20.000000Z",
"source": "foxbusiness.com",
"relevance_score": null,
"entities": [
{
"symbol": "ACVF",
"name": "American Conservative Values ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 35.355373,
"sentiment_score": 0.2732,
"highlights": [
{
"highlight": "The <em>American</em> <em>Conservative</em> <em>Values</em> <em>ETF</em>, an actively managed exchange-traded fund created by Ridgeline Research LLC to cater to ideologically conservative investors, announced Monday that it divested its holdings of Tyson Foods and placed a \"refuse to buy\" rating on the food giant's stock.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "2b86cb13-9183-40bd-bc3d-94e279418288",
"title": "Passive Investing Is Starting To Break The Market",
"description": "Passive share of investing continues to rise, reaching over 50% of total assets managed in December 2023. Click here to read how this distorts markets.",
"keywords": "",
"snippet": "gopixa\n\nFinancial theory suggests that there is a limit to how high passive investing can get as a percentage of total investing before it breaks the market, bu...",
"url": "https://seekingalpha.com/article/4678974-passive-investing-is-starting-to-break-the-market",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1472468191/image_1472468191.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T20:42:42.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "VNQ",
"name": "Vanguard Real Estate Index Fund ETF Shares",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 31.236153,
"sentiment_score": 0.2666,
"highlights": [
{
"highlight": "Someone might sell the <em>Vanguard</em> <em>Real</em> <em>Estate</em> <em>Index</em> <em>Fund</em> <em>ETF</em> <em>Shares</em> (VNQ) after hearing a negative report on the state of commercial real estate (meaning office), and in so doing they are also selling shares of KIM.\n\nThus, due to really high passive share, it is actually possible for KIM to trade down even in the absence of bearishness on KIM.",
"sentiment": 0.2666,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b1667011-f0ef-4edc-8b3f-d2aad0bedc40",
"title": "SPY Is Expensive, But There Are Hiding Places",
"description": "SPDR S&P 500 Trust ETF has become expensive. Click here for some of the alternative investment ideas.",
"keywords": "",
"snippet": "Eoneren\n\nThesis\n\nThe goal of this article is twofold, both quite straightforward. First, it will analyze how expensive the SPDR S&P 500 Trust ETF (NYSEARCA:SPY)...",
"url": "https://seekingalpha.com/article/4678973-spy-is-expensive-but-there-are-hiding-places",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1132930101/image_1132930101.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T20:36:39.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "XLF",
"name": "Financial Select Sector SPDR Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 25.737991,
"sentiment_score": 0.5106,
"highlights": [
{
"highlight": "The first additional alternative idea involves the <em>Financial</em> <em>Select</em> <em>Sector</em> <em>SPDR</em> <em>Fund</em> ETF (XLF). Our thoughts are detailed in an earlier article here. The fund has appreciated sizably since then.",
"sentiment": 0.5106,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "SPY",
"name": "SPDR S&P 500 ETF Trust",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 12.47006,
"sentiment_score": 0.8834,
"highlights": [
{
"highlight": "First, it will analyze how expensive the SPDR S&P 500 Trust ETF (<em>NYSEARCA:SPY</em>) has really become after its recent rallies. And second, it will analyze some of the alternative places to invest in case we successfully accomplish our first goal and convince you how expensive SPY currently is.",
"sentiment": 0.8834,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "7651af2e-9bda-49e0-8373-5bc5c3edb6f0",
"title": "TikTok Ban: China Has The Power To Block Sale, Gains Leverage Over Washington - Invesco QQQ Trust, Series 1 (NASDAQ:QQQ), Meta Platforms (NASDAQ:META)",
"description": "The House passed a bill that could ban TikTok in the U.S. unless its Chinese owner, ByteDance, sells its U.S. operations.",
"keywords": "",
"snippet": "Loading... Loading...\n\nLast week, the House of Representatives moved forward on a bill that could ban TikTok in the U.S. unless it is sold by its owner ByteDanc...",
"url": "https://www.benzinga.com/markets/asia/24/03/37800098/tiktok-ban-china-has-the-power-to-block-sale-gains-leverage-over-washington",
"image_url": "https://cdn.benzinga.com/files/images/story/2024/TikTok-ban_1.jpeg?width=1200&height=800&fit=crop",
"language": "en",
"published_at": "2024-03-18T20:07:26.000000Z",
"source": "benzinga.com",
"relevance_score": null,
"entities": [
{
"symbol": "XLC",
"name": "Communication Services Select Sector SPDR Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 45.754677,
"sentiment_score": 0.3182,
"highlights": [
{
"highlight": "-listed social media apps include <em>Communication</em> <em>Services</em> <em>Select</em> <em>Sector</em> <em>SPDR</em> <em>Fund</em> XLC, Invesco QQQ Trust Series 1 QQQ and Vanguard Growth Index Fund ETF VUG.\n\nWhat The Bill Means For U.S.-China Relations\n\nA ban on TikTok, which has been talked about in Washington for years, could have vast consequences for U.S.-China relations.",
"sentiment": 0.3182,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "a81a6446-7f44-4ac8-be37-19bceb4345e2",
"title": "Commodities superam ações em 2024: reversão à média ou mudança de tendência?",
"description": "Análises de Ações por James Picerno abrangendo: iShares S&P GSCI Commodity-Indexed Trust, Vanguard Total Stock Market Index Fund ETF Shares, Petróleo WTI Futuros, Invesco DB Commodity Index Tracking Fund. Leia as Análises de Ações de James Picerno no Investing.com.",
"keywords": "",
"snippet": "GSG +1,33% Adicionar/Remover de uma Carteira VTI +0,51% Adicionar/Remover de uma Carteira CL 0,00% Adicionar/Remover de uma Carteira DBC +0,92% Adicionar/Remove...",
"url": "https://br.investing.com/analysis/commodities-superam-acoes-em-2024-reversao-a-media-ou-mudanca-de-tendencia-200463240",
"image_url": "https://i-invdn-com.investing.com/redesign/images/seo/investingcom_analysis_og.jpg",
"language": "pt",
"published_at": "2024-03-18T19:05:00.000000Z",
"source": "br.investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "DBA",
"name": "Invesco DB Agriculture Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 42.527496,
"sentiment_score": null,
"highlights": [
{
"highlight": "Os produtos agrícolas também estão em alta este ano: o <em>Invesco</em> <em>DB</em> <em>Agriculture</em> <em>Fund</em> (NYSE: ) valorizou 13,4% desde janeiro.\n\nResta saber se o bom momento das commodities em 2024 é uma simples correção ou o início de uma nova era para esse tipo de investimento.",
"sentiment": null,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DBC",
"name": "Invesco DB Commodity Index Tracking Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 59.81305,
"sentiment_score": null,
"highlights": [
{
"highlight": "Por exemplo, o <em>Invesco</em> <em>DB</em> <em>Commodity</em> <em>Index</em> <em>Tracking</em> <em>Fund</em> (NYSE: ) mostra um ganho mais modesto de 3,3% desde o início do ano.\n\nMas o fato de alguns fundos de commodities estarem agora à frente das ações dos EUA sinaliza uma possível mudança de direção para esses investimentos.",
"sentiment": -0.2837,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "GSG",
"name": "iShares S&P GSCI Commodity-Indexed Trust",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 75.322876,
"sentiment_score": null,
"highlights": [
{
"highlight": "Por exemplo, o <em>iShares</em> <em>S</em>&<em>P</em> <em>GSCI</em> <em>Commodity</em>-<em>Indexed</em> <em>Trust</em> (NYSE: ) está, até agora, com um desempenho melhor que as ações dos EUA (VTI).\n\nÉ verdade que definir um padrão para investimentos em commodities é complexo e pode levar a resultados variados.",
"sentiment": -0.2837,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "VTI",
"name": "Vanguard Total Stock Market Index Fund ETF Shares",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 59.670128,
"sentiment_score": null,
"highlights": [
{
"highlight": "Esse crescimento das commodities em 2024 ultrapassou o avanço de 7,0% das ações americanas, representadas pelo <em>Vanguard</em> <em>Total</em> <em>Stock</em> <em>Market</em> <em>Index</em> <em>Fund</em> <em>ETF</em> <em>Shares</em> (NYSE: ), que viu uma pequena queda de 0,3% na última semana.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "e4fcceea-9eb9-4f93-8768-9a90babeadd5",
"title": "IXJ: Healthcare Sector Dashboard For March (NYSEARCA:IXJ)",
"description": "The healthcare sector is overvalued with variations across subsectors. Find out why we think iShares Global Healthcare ETF is a global alternative to XLV.",
"keywords": "",
"snippet": "shapecharge\n\nThis monthly article series shows a dashboard with aggregate industry metrics in healthcare. It is also a review of healthcare ETFs whose largest h...",
"url": "https://seekingalpha.com/article/4678943-ixj-healthcare-sector-dashboard-for-march",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/592647720/image_592647720.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T18:07:39.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "IXJ",
"name": "iShares Global Healthcare ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 93.648026,
"sentiment_score": 0.416067,
"highlights": [
{
"highlight": "It is also a review of healthcare ETFs whose largest holdings have been used to calculate these metrics, like the Health Care Select Sector SPDR Fund ETF (XLV) and <em>iShares</em> <em>Global</em> <em>Healthcare</em> <em>ETF</em> (<em>NYSEARCA:IXJ</em>).\n\nShortcut\n\nThe next two paragraphs in italics describe the dashboard methodology.",
"sentiment": 0.6908,
"highlighted_in": "main_text"
},
{
"highlight": "IXJ: An alternative to XLV\n\n<em>iShares</em> <em>Global</em> <em>Healthcare</em> <em>ETF</em> started investing operations on 11/13/2001 and tracks the S&P Global 1200 Health Care Index. It has a portfolio of 114 stocks and an expense ratio of 0.42%, whereas capital-weighted healthcare ETFs focused on US equities have much lower fees (0.09% for XLV).",
"sentiment": 0.5574,
"highlighted_in": "main_text"
},
{
"highlight": "IXJ: Healthcare Sector Dashboard For March (<em>NYSEARCA:IXJ</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "RYH",
"name": "Invesco S&P 500 Equal Weight Health Care ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 53.086517,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "Investors who seek a more balanced portfolio, and don't need international exposure, may prefer <em>Invesco</em> <em>S</em>&<em>P</em> <em>500</em> <em>Equal</em> <em>Weight</em> <em>Health</em> <em>Care</em> <em>ETF</em> (RSPH).\n\nDashboard List\n\nI use the first table to calculate value and quality scores. It may also be used in a stock-picking process to check how companies stand among their peers.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "XLV",
"name": "Health Care Select Sector SPDR Fund",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 36.84452,
"sentiment_score": 0.3612,
"highlights": [
{
"highlight": "It is also a review of healthcare ETFs whose largest holdings have been used to calculate these metrics, like the <em>Health</em> <em>Care</em> <em>Select</em> <em>Sector</em> <em>SPDR</em> <em>Fund</em> ETF (XLV) and iShares Global Healthcare ETF (NYSEARCA:IXJ).\n\nShortcut\n\nThe next two paragraphs in italics describe the dashboard methodology.",
"sentiment": 0.3612,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "b7eb1d8f-7285-4291-a8de-cccac880166d",
"title": "Retail Sector Earnings Roundup: Analyzing The Winners And Losers (NYSEARCA:XRT)",
"description": "While investors have bid up most value-based retailers, investors have had less to cheer with dollar stores. Read more to see a review of retail sector earnings.",
"keywords": "",
"snippet": "FreshSplash\n\nThe holiday earnings season for retailers is nearly wrapped up, with most having reported results from mid-February through mid-March.\n\nThe current...",
"url": "https://seekingalpha.com/article/4678869-retail-sector-earnings-roundup-analyzing-winners-losers",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1729402032/image_1729402032.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T13:15:20.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "XRT",
"name": "SPDR S&P Retail ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 69.64256,
"sentiment_score": 0.20835,
"highlights": [
{
"highlight": "Investors seeking more diversified exposure could also opt for the <em>SPDR</em> <em>S</em>&<em>P</em> <em>Retail</em> <em>ETF</em> (<em>NYSEARCA:XRT</em>). The ETF includes the dollar stores among its holdings. It also includes top performing names, such as Abercrombie. The stock, however, may have already run its course, with yearly gains of over 20%, including 5% YTD.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Retail Sector Earnings Roundup: Analyzing The Winners And Losers (<em>NYSEARCA:XRT</em>)",
"sentiment": -0.0772,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "384bcf66-d73c-412e-80a6-cf78a1000b93",
"title": "SCHD: Reconstitution But Familiar Names Remain, Still Generating Additional 'Income'",
"description": "Schwab U.S. Dividend Equity ETF recently underwent an annual reconstitution and delivered an attractive yield of 3.77% with growth. Learn more about SCHD here.",
"keywords": "",
"snippet": "PM Images\n\nWritten by Nick Ackerman.\n\nSchwab U.S. Dividend Equity ETF™ (NYSEARCA:SCHD) recently went through its annual reconstitution on March 15th, 2024. We...",
"url": "https://seekingalpha.com/article/4678936-schd-reconstitution-but-familiar-names-remain-still-generating-additional-income",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1462296278/image_1462296278.jpg?io=getty-c-w1536",
"language": "en",
"published_at": "2024-03-18T17:49:14.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "SCHD",
"name": "Schwab U.S. Dividend Equity ETF",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "etf",
"industry": "N/A",
"match_score": 48.036385,
"sentiment_score": 0.4201,
"highlights": [
{
"highlight": "<em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em>™ (<em>NYSEARCA:SCHD</em>) recently went through its annual reconstitution on March 15th, 2024. We had already seen a preview of what changes there would be, as this is a passively managed fund based on the Dow Jones U.S. Dividend 100 Index.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Conclusion\n\nOverall, the <em>Schwab</em> <em>U.S</em>. <em>Dividend</em> <em>Equity</em> <em>ETF</em> has provided a solid and growing dividend for investors holding the shares. The passive nature based on a screening process keeps investors disciplined, even if it means selling out what appear to be solid winners.",
"sentiment": 0.8402,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NYSEARCA",
"total_documents": 75,
"sentiment_avg": 0.33998785378492397
}
]
}
Other details
Country
- us
- 1,930